Episode 6: Tomas Philipson – Free Riders and Price Controls: The Global Economics of Drug Innovation
In this episode, Tomas Philipson, a professor at the University of Chicago and former acting chair of the Council of […]
Episode 5: Tony Losasso – The Next Claritin? GLP-1 Drugs and the Future of Obesity Treatment
In this episode, Tony Losasso, a professor of economics and Driehaus Fellow at Depaul University, discusses his experiences in public
The HEAL Network Shines at the 14th Annual ASHEcon Conference in Nashville
The Health Economists and Academic Leaders Network (HEAL Network) was delighted to support and participate in the 14th Annual Conference
HEAL Blog: New research shows small molecule drugs contribute to national-level wage and hour gains.
The Inflation Reduction Act (IRA) represents a landmark shift in U.S. drug pricing regulation, introducing direct federal negotiation of drug
Episode 4: Doug Holtz-Eakin – Pharmaceutical Policy, Drug Pricing, and the Cost of Bad Policy
In EP4, Bryana Meyer joins us to talk with Doug Holtz-Eakin, former CBO head and president of the American Action
Episode 3: Marta Wosinska – Drug Shortages and How to Prevent Them
On this episode, Marta Wosinska of the Brookings Institution talks about drug shortages and the challenges of preventing them.
Episode 2: Karen Mandelbaum – CMS Privacy Standard for the Public Health Exchanges
In EP2, we interview Karen Mandelbaum at Epstein Becker Green and discuss her work at CMS drafting privacy standards for